PL BioScience
The platform of tailored cell culture supplements based on human Platelets.
Launch date
Employees
Market cap
-
Enterprise valuation
€31—47m (Dealroom.co estimates Aug 2024.)
Company register number HRB 19554
Aachen Nordrhein-Westfalen (HQ)
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Profit | (<1m) | (<1m) | (<1m) | (1.2m) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Early VC | ||
€3.7m | Seed | ||
* | €7.8m | Series A | |
Total Funding | €11.5m |
Related Content
Recent News about PL BioScience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.